Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Collaboration › Details

Waters–JPMorgan Chase: investor conference, 201701 supply service Waters presents at JP Morgan Healthcare Conference 2017

 

Period Period 2017-01-09
Region Region San Francisco, CA
  Country United States (USA)
  Successor Waters–JPMorgan Chase: investor conference, 201801 supply service Waters presents at JP Morgan Healthcare Conference 2018
Organisations Partner, 1st Waters Corporation (NYSE: WAT)
  Group Waters (Group)
  Partner, 2nd J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 35th Annual Healthcare Conference 2017 San Francisco
  Product 2 laboratory equipment and instruments
Persons Person O’Connell, Christopher J. (Chris) (Waters 201509–202009 CEO before over 21 years at Medtronic)
  Person 2 Lynch, John (Waters 201404 VP Investor Relations)
     

Waters Corporation. (1/3/17). "Press Release: Waters Corporation Presentation at the 35th Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live". Milford, MA.

Waters Corporation (NYSE:WAT) Christopher J. O’Connell, Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 9, 2017, at 8:30 a.m. Pacific Time.

Interested investors can access the live webcast of the presentation by logging on to Waters Corporation’s website, www.waters.com in the investor relations’ section and clicking on “J.P. Morgan Healthcare Conference.”


About Waters Corporation:

For over 5O years, Waters Corporation (NYSE:WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $2.0 billion in 2015, Waters is driving scientific discovery and operational excellence for customers worldwide.


Waters Corporation
John Lynch, 508-482-2314
V.P. Investor Relations

   
Record changed: 2018-01-09

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Waters (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top